Cargando…
Combined targeted therapy and immunotherapy for cancer treatment
Although targeted therapies and immunotherapies have been effective against several malignancies, the respective monotherapies are limited by low and/or short-term responses. Specific inhibitors of oncogenic signaling pathways and tumor-associated angiogenesis can activate the anti-tumor immune resp...
Autores principales: | Guo, Cheng-Xiang, Huang, Xing, Xu, Jian, Zhang, Xiao-Zhen, Shen, Yi-Nan, Liang, Ting-Bo, Bai, Xue-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462242/ https://www.ncbi.nlm.nih.gov/pubmed/34621816 http://dx.doi.org/10.12998/wjcc.v9.i26.7643 |
Ejemplares similares
-
Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma
por: Contratto, Merly, et al.
Publicado: (2018) -
Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations
por: Guo, Songchuan, et al.
Publicado: (2017) -
Targeting cytotoxic T lymphocytes for cancer immunotherapy
por: Maher, J, et al.
Publicado: (2004) -
Targets of immunotherapy for hepatocellular carcinoma: An update
por: Rai, Vikrant, et al.
Publicado: (2022) -
Progress in immunotherapy for small cell lung cancer
por: Zhao, Dong, et al.
Publicado: (2020)